Michael Fradley, MD, and Naveen Pemmaraju, MD, provide overview of treatment landscape of chronic myeloid leukemia, review cardiovascular toxicities of BCR-ABL TKIs, and discuss role of social media in cardio-oncology. Moderated by Sarah Waliany, MD, MS.
